MiNA Therapeutics
0 Followers
About
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
- Website
- Headquarters
- Industry
- Social
Team
View all (26)
Robert Habib Mba
CEO
Nagy Habib
Founder, Chairman & Head of R&D
Peter Bains
Chief Business Officer
Robert Nutbrown
Director, Clinical Operations
David Blakey
SVP, Strategic Alliances
Vikash Reebye
Principal Scientist
Matt Catley
Research Director
Joanna Nicholls
Clinical Trial Manager
Andrew Bentley
QA Manager
Becky Palmer
Lab Manager
Sushma Haria
Office Manager
Karin Purdie
Research Scientist
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.